Enhancer Connectome Nominates Target Genes of Inherited Risk Variants from Inflammatory Skin Disorders.


Journal

The Journal of investigative dermatology
ISSN: 1523-1747
Titre abrégé: J Invest Dermatol
Pays: United States
ID NLM: 0426720

Informations de publication

Date de publication:
03 2019
Historique:
received: 29 03 2018
revised: 24 08 2018
accepted: 18 09 2018
pubmed: 14 10 2018
medline: 25 2 2020
entrez: 14 10 2018
Statut: ppublish

Résumé

The vast majority of polymorphisms for human dermatologic diseases fall in noncoding DNA regions, leading to difficulty interpreting their functional significance. Recent work using chromosome conformation capture technology in combination with chromatin immunoprecipitation (ChIP) has provided a systematic means of linking noncoding variants in active enhancer loci to putative gene targets. Here, we apply H3K27ac HiChIP high-resolution contact maps, generated from primary human T-cell subsets (CD4

Identifiants

pubmed: 30315781
pii: S0022-202X(18)32657-5
doi: 10.1016/j.jid.2018.09.011
pii:
doi:

Substances chimiques

Chromatin 0
Histones 0
Interferon Regulatory Factors 0
STAT Transcription Factors 0
interferon regulatory factor-8 0
Ikaros Transcription Factor 148971-36-2
Janus Kinases EC 2.7.10.2

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

605-614

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Mark Y Jeng (MY)

Department of Dermatology, Stanford University School of Medicine, Redwood City, California, USA.

Maxwell R Mumbach (MR)

Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.

Jeffrey M Granja (JM)

Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA; Department of Genetics, Stanford University School of Medicine, Stanford, California, USA.

Ansuman T Satpathy (AT)

Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA; Department of Pathology, Stanford University School of Medicine, Stanford, California, USA.

Howard Y Chang (HY)

Center for Personal Dynamic Regulomes, Stanford University School of Medicine, Stanford, California, USA; Program in Epithelial Biology, Stanford University School of Medicine, Stanford, California, USA.

Anne Lynn S Chang (ALS)

Department of Dermatology, Stanford University School of Medicine, Redwood City, California, USA. Electronic address: alschang@stanford.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH